“I Don't Really Agree With That:” Canadians' Perspectives on the 14‐Day Rule in Relation to Artificial Womb Technology
Perspectives on Sexual and Reproductive Health · 2025-03 · 57 (1) · 104-113
DOI: 10.1111/psrh.70005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives on Sexual and Reproductive Health, online erschienen am 05.03.2025. Verfasst von Srishti Hukku und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Complete ectogenesis through artificial womb technology (AWT) would enable fertilization, embryonic development, and fetal development outside of the human body. In 2004, Canada's Assisted Human Reproduction Act established a 14‐day legal limit on the in vitro cultivation of human embryos, stymying the domestic development of AWT. Given recent scientific advancements, we aimed to explore Canadians' perspectives on the 14‐day rule and AWT development.
Methods
In September 2020–February 2021, we conducted an online English‐French survey and semi‐structured in‐depth interviews with a subset of respondents to solicit Canadian citizens' perspectives on AWT. We audio‐recorded and transcribed the telephone/Zoom/Skype interviews and used ATLAS.ti to manage our data. We analyzed survey data using descriptive statistics and interviews for content and themes using inductive and deductive techniques.
Results
We received 343 completed surveys and conducted 41 interviews. Although overall knowledge of AWT, in general, and the 14‐day rule, in particular, was limited, our participants felt that AWT had the potential to improve lives. Participants also perceived the 14‐day rule as an outdated limitation on technological progress and a barrier to AWT development. Participants suggested revisiting the legislation and emphasized centering science, technology, and medicine in any update.
Discussion
In 2021, the International Society for Stem Cell Research released updated guidelines which recommended relaxing the 14‐day rule, depending on the research objectives. Given the changing domestic and international landscape, Canadian policymakers should revisit the 14‐day rule limit imposed by the Assisted Human Reproduction Act and seek input from Canadians when embarking on this reform process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences, University of Ottawa, Ontario, Canada.
- School of Social Sciences, Macquarie University, New South Wales, Australia.
- Collaborative for Interdisciplinary Global Abortion Research, Ontario, Canada.
Zitieren
APA
Hukku, S., Wynn, L. L., & Foster, A. M. (2025). “I Don't Really Agree With That:” Canadians' Perspectives on the 14‐Day Rule in Relation to Artificial Womb Technology. Perspectives on Sexual and Reproductive Health, 57(1), 104-113. https://doi.org/10.1111/psrh.70005
Vancouver
Hukku S, Wynn LL, Foster AM. “I Don't Really Agree With That:” Canadians' Perspectives on the 14‐Day Rule in Relation to Artificial Womb Technology. Perspectives on Sexual and Reproductive Health. 2025;57(1):104-113. doi:10.1111/psrh.70005
BibTeX
@article{Hukku2025,
author = {Hukku, Srishti and Wynn, Lisa L and Foster, Angel M},
title = {“I Don't Really Agree With That:” Canadians' Perspectives on the 14‐Day Rule in Relation to Artificial Womb Technology},
journal = {Perspectives on Sexual and Reproductive Health},
year = {2025},
volume = {57},
number = {1},
pages = {104--113},
doi = {10.1111/psrh.70005}
}
EUVIMED